Light Sciences Oncology Secures $6,256,000 New Funding Round

  • Feed Type
  • Date
    6/13/2011
  • Company Name
    Light Sciences Oncology
  • Mailing Address
    15405 SE 37th Street Bellevue, WA 98006
  • Company Description
    Light Sciences Oncology is developing Light Infusion Therapy (Litx), an innovative light-activated treatment for solid tumors. LSO is currently developing Litx for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy.
  • Website
    http://www.lsoncology.com
  • Transaction Type
    Debt
  • Transaction Amount
    $6,256,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.